Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

EU Health Claim Regulation Leaves EFSA Wary Of Five-Month Review Deadline

This article was originally published in The Tan Sheet

Executive Summary

The European Food Standards Agency is "concerned" about the five-month deadline for review of proposed health claims that has been imposed by the newly adopted Nutrition & Health Claims Regulation, and is hopeful that industry will be cooperative if the agency is unable to meet the deadline due to increased workload, according to an EFSA director

You may also be interested in...



EU health claims

The European Union Council of Ministers has adopted the Nutrition & Health Claims Regulation, which aims to harmonize regulation of health claims across the EU, according to an announcement by the council Oct 12. The adopted provisions would establish a positive list of approved health claims within three years of the regulation's publication in the Official Journal of the EU. Once the list is established, claims based on new scientific data will need approval from the European Food Safety Authority. The regulation would apply to product claims made on packaging or websites, and would ban all claims related to rates or amounts of weight loss. The regulation was adopted by the EU Parliament in May (1"The Tan Sheet" May 22, 2006, p. 9)...

Fraud Discovery Institute Asks Waxman To Address Lead In Herbalife Products

FDA should issue a public health alert to warn consumers about potential health risks that may result from use of Herbalife dietary supplements and should remove the company's products from the market, pending further investigation of lead contamination, according to Christopher Grell, an attorney whose firm specializes in ephedra and dietary supplement litigation

Fraud Discovery Institute Asks Waxman To Address Lead In Herbalife Products

FDA should issue a public health alert to warn consumers about potential health risks that may result from use of Herbalife dietary supplements and should remove the company's products from the market, pending further investigation of lead contamination, according to Christopher Grell, an attorney whose firm specializes in ephedra and dietary supplement litigation

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS099979

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel